Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Sewell

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Biochemical Pharmacology|August 17, 1994
Intracellular binding is an important determinant of the avid hepatic uptake of the high clearance drug omeprazoleR B Sewell, C W Brook, G W Mihaly, et al.
Gut|June 1, 1995
Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver GroupR G Watson, P W Angus, M Dewar, et al.
The Medical Journal of Australia|May 20, 1991
Augmentin-induced jaundiceF S Wong, J Ryan, P Dabkowski, et al.
Gut|February 15, 2000
Diagnosis of Wilson's disease: an experience over three decadesP J Gow, R A Smallwood, P W Angus, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|September 1, 1999
Bone loss at the proximal femur and reduced lean mass following liver transplantation: a longitudinal studyJ B Keogh, C Tsalamandris, R B Sewell, et al.
Gut|December 1, 1988
Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patientsE G Hewson, N D Yeomans, P W Angus, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
The effect of hepatic cirrhosis on the pharmacokinetics and blood pressure response to nicardipineT A Razak, J J McNeil, R B Sewell, et al.
Australian and New Zealand Journal of Medicine|April 1, 1994
Transjugular intrahepatic portal-systemic shunts (TIPS)--initial experience and clinical outcomeG S Hebbard, G Fitt, K R Thomson, et al.
British Medical Journal (Clinical Research Ed.)|March 14, 1981
Evidence for a circulating sodium transport inhibitor in essential hypertensionL Poston, R B Sewell, S P Wilkinson, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biochemical Pharmacology|August 17, 1994
Intracellular binding is an important determinant of the avid hepatic uptake of the high clearance drug omeprazoleR B Sewell, C W Brook, G W Mihaly, et al.
Gut|June 1, 1995
Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver GroupR G Watson, P W Angus, M Dewar, et al.
The Medical Journal of Australia|May 20, 1991
Augmentin-induced jaundiceF S Wong, J Ryan, P Dabkowski, et al.
Gut|February 15, 2000
Diagnosis of Wilson's disease: an experience over three decadesP J Gow, R A Smallwood, P W Angus, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|September 1, 1999
Bone loss at the proximal femur and reduced lean mass following liver transplantation: a longitudinal studyJ B Keogh, C Tsalamandris, R B Sewell, et al.
Gut|December 1, 1988
Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patientsE G Hewson, N D Yeomans, P W Angus, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
The effect of hepatic cirrhosis on the pharmacokinetics and blood pressure response to nicardipineT A Razak, J J McNeil, R B Sewell, et al.
Australian and New Zealand Journal of Medicine|April 1, 1994
Transjugular intrahepatic portal-systemic shunts (TIPS)--initial experience and clinical outcomeG S Hebbard, G Fitt, K R Thomson, et al.
British Medical Journal (Clinical Research Ed.)|March 14, 1981
Evidence for a circulating sodium transport inhibitor in essential hypertensionL Poston, R B Sewell, S P Wilkinson, et al.
Pageof 4